Fusion Pharmaceuticals Inc. Quarterly Entity Common Stock, Shares Outstanding from Q2 2020 to Q1 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Fusion Pharmaceuticals Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2020 to Q1 2024.
  • Fusion Pharmaceuticals Inc. Entity Common Stock, Shares Outstanding for the quarter ending April 3, 2024 was 84.9M shares, a 34.3% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 84.9M +21.7M +34.3% Apr 3, 2024 10-K/A 2024-04-12
Q3 2023 72.4M +27.6M +61.8% Oct 27, 2023 10-Q 2023-11-07
Q2 2023 69M +25.6M +59% Jul 28, 2023 10-Q 2023-08-08
Q1 2023 63.2M +19.9M +45.8% Mar 6, 2023 10-K 2023-03-16
Q3 2022 44.8M +1.7M +3.94% Oct 28, 2022 10-Q 2022-11-08
Q2 2022 43.4M +371K +0.86% Jul 29, 2022 10-Q 2022-08-09
Q1 2022 43.3M +1.49M +3.55% Mar 7, 2022 10-K 2022-03-17
Q3 2021 43.1M +1.34M +3.21% Nov 2, 2021 10-Q 2021-11-09
Q2 2021 43M +1.36M +3.25% Aug 3, 2021 10-Q 2021-08-10
Q1 2021 41.8M Mar 15, 2021 10-K 2021-03-25
Q3 2020 41.7M Nov 3, 2020 10-Q 2020-11-10
Q2 2020 41.7M Aug 4, 2020 10-Q 2020-08-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.